drugset / Trial / NCT00154115

Levosimendan in High Risk Heart Valve Surgery

NCT00154115

Phase 4 Completed 200 enrolled Kuopio University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Prospective, randomized, double blind study investigating the efficacy of levosimendan in heart failure after cardiac surgery. Study hypothesis: Levosimendan diminishes the need for adrenergic inotropic drugs and morbidity and may improve survival after heart valve surgery.

Timeline

Start
2005-03
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Levosimendan Other / unclassified 0.2 ug/kg Intravenous

Indications